About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
QLGN
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Qualigen Therapeutics GAAP EPS of -$4.85 misses by $3.60, revenue of $5M beats by $3.43M
- Qualigen Therapeutics receives non-compliance notice from Nasdaq for delayed form 10-K filing
- Qualigen stock soars 15% on FDA orphan drug status for pancreatic cancer therapy
- Qualigen Therapeutics regains compliance with Nasdaq minimum bid price rule
- Qualigen Therapeutics announces 1-for-10 reverse stock split
- Qualigen Therapeutics GAAP EPS of -$0.10 beats by $0.06, revenue of $1.44M misses by $0.18M
- Qualigen Therapeutics GAAP EPS of -$0.11 beats by $0.06, revenue of $1.4M beats by $0.05M
- Qualigen Therapeutics files mixed shelf offering of up to $150M
- Qualigen partners Hande Sciences to support its application enabling studies for QN-302
- Qualigen Therapeutics announces secondary offering of 8.16M shares
- Qualigen begins IND-enabling studies to advance potential cancer treatment toward clinical trials
- Qualigen stock rises on acquiring majority stake in Israeli diagnostics company NanoSynex
- Qualigen Therapeutics GAAP EPS of -$0.12 beats by $0.07, revenue of $0.72M misses by $0.14M
- Qualigen to acquire majority stake in Israeli diagnostics company NanoSynex
- Qualigen Therapeutics climbs 3% on resuming worldwide distribution and commercial control over Fastpack
- Qualigen Therapeutics GAAP EPS of -$0.61, revenue of $5.65M
- Qualigen contracts TD2 for preclinical development of QN-302
- Petros Pharma, Qualigen see dramatic rises amid social media buzz, short squeezes
- Qualigen Therapeutics EPS beats by $0.11, misses on revenue
- Virpax Pharmaceuticals, Sesen Bio leads healthcare gainers; Qualigen Therapeutics, Sema4 among major losers
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| December 29, 2021 | - / -0.195 | - / 1.36M | |
| November 15, 2021 | -0.1 / -0.195 | 1.16M / 1.34M | |
| September 1, 2021 | -0.13 / -0.18 | 1.9M / 1.4M |
Beat! |
| August 17, 2021 | -0.18 / -0.18 | 1.12M / 1.7M | |
| May 14, 2021 | -0.13 / -0.14 | 1.9M / 1.2M |
Beat! |
| March 30, 2021 | - / -0.13 | - / 1.3M | |
| February 11, 2021 | 0.31 / -0.12 | 1.1M / 1.2M | |
| August 14, 2020 | -2.12 / -0.75 | 904.07K / - |
Beat! |
| May 1, 2020 | -1.21 / -1.21 | 904.07K / - |
Beat! |
| March 31, 2020 | -1.25 / -1.50 | 904.1K / - |
Beat! |
| November 14, 2019 | -5.75 / -5.75 | 904.1K / - |
Beat! |
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25 | 0.390 | 0.399 |
0.399
|
0.380
|
337.26K | 0% | ||||
| Aug 24 | 0.390 | 0.400 |
0.400
|
0.380
|
190.02K | -2.99% | ||||
| Aug 23 | 0.402 | 0.410 |
0.410
|
0.390
|
226.08K | -0.74% | ||||
| Aug 22 | 0.405 | 0.409 |
0.420
|
0.400
|
96.78K | -1.22% | ||||
| Aug 19 | 0.410 | 0.418 |
0.420
|
0.400
|
54.58K | -2.38% | ||||
| Aug 18 | 0.420 | 0.425 |
0.429
|
0.400
|
188.27K | -0.99% | ||||
| Aug 17 | 0.424 | 0.428 |
0.430
|
0.402
|
175.32K | 1.95% | ||||
| Aug 16 | 0.416 | 0.434 |
0.434
|
0.410
|
232.32K | -2.09% | ||||
| Aug 15 | 0.425 | 0.420 |
0.445
|
0.419
|
279.50K | -0.35% | ||||
| Aug 12 | 0.426 | 0.440 |
0.445
|
0.415
|
125.74K | 0.35% | ||||
| Aug 11 | 0.425 | 0.439 |
0.448
|
0.415
|
221.56K | 0% | ||||
| Aug 10 | 0.425 | 0.422 |
0.440
|
0.422
|
283.11K | 2.16% | ||||